News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
874,797 Results
Type
Article (88268)
Company Profile (812)
Press Release (785697)
Multimedia
Podcasts (212)
Webinars (33)
Section
Business (233379)
Career Advice (4152)
Deals (39902)
Drug Delivery (160)
Drug Development (91505)
Employer Resources (205)
FDA (18461)
Job Trends (17445)
News (398212)
Policy (40002)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3027)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (169)
Alliances (56982)
ALS (199)
Alzheimer's disease (1854)
Antibody-drug conjugate (ADC) (397)
Approvals (18662)
Artificial intelligence (704)
Autoimmune disease (227)
Automation (49)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (214)
Biotechnology (486)
Bladder cancer (181)
Brain cancer (71)
Breast cancer (715)
Cancer (5498)
Cardiovascular disease (489)
Career advice (3580)
Career pathing (44)
CAR-T (323)
CDC (68)
Celiac Disease (2)
Cell therapy (894)
Cervical cancer (42)
Clinical research (77627)
Collaboration (2012)
Company closure (6)
Compensation (1277)
Complete response letters (91)
COVID-19 (3010)
CRISPR (110)
C-suite (1009)
Cystic fibrosis (157)
Data (6946)
Decentralized trials (2)
Denatured (78)
Depression (173)
Diabetes (575)
Diagnostics (7373)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (345)
Drug pricing (233)
Drug shortages (36)
Duchenne muscular dystrophy (280)
Earnings (101013)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136183)
Executive appointments (1094)
FDA (21915)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (28)
Funding (1683)
Gene editing (236)
Generative AI (73)
Gene therapy (739)
GLP-1 (1186)
Government (5493)
Grass and pollen (8)
Guidances (394)
Healthcare (20993)
HIV (77)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (316)
Immuno-oncology (86)
Indications (146)
Infectious disease (3345)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (277)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (101)
Layoffs (665)
Leadership (44)
Legal (10169)
Liver cancer (102)
Longevity (26)
Lung cancer (730)
Lymphoma (402)
Machine learning (51)
Management (66)
Manufacturing (974)
MASH (190)
Medical device (15120)
Medtech (15198)
Mergers & acquisitions (23072)
Metabolic disorders (1541)
mRNA (210)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (413)
Neuropsychiatric disorders (112)
Neuroscience (3332)
Neurotech (1)
NextGen: Class of 2026 (7712)
Non-profit (5127)
Now hiring (72)
Obesity (753)
Opinion (351)
Ovarian cancer (179)
Pain (239)
Pancreatic cancer (258)
Parkinson's disease (345)
Partnered (39)
Patents (566)
Patient recruitment (582)
Peanut (65)
People (67278)
Pharmaceutical (139)
Pharmacy benefit managers (34)
Phase 1 (23980)
Phase 2 (33688)
Phase 3 (25372)
Pipeline (6644)
Policy (367)
Postmarket research (3554)
Preclinical (10770)
Press Release (72)
Prostate cancer (282)
Psychedelics (61)
Radiopharmaceuticals (321)
Rare diseases (1064)
Real estate (7445)
Recruiting (81)
Regulatory (29489)
Reports (70)
Research institute (2751)
Resumes & cover letters (653)
Rett syndrome (32)
RNA editing (21)
RSV (92)
Schizophrenia (168)
Series A (285)
Series B (209)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (50)
Startups (4344)
State (2)
Stomach cancer (21)
Supply chain (124)
Tariffs (101)
The Weekly (131)
Vaccines (1204)
Venture capital (106)
Weight loss (514)
Women's health (111)
Worklife (23)
Date
Today (164)
Last 7 days (605)
Last 30 days (3323)
Last 365 days (32874)
2026 (7125)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (95)
Alaska (7)
Arizona (362)
Arkansas (15)
Asia (51765)
Australia (9097)
California (12494)
Canada (3547)
China (1267)
Colorado (530)
Connecticut (551)
Delaware (373)
Europe (119187)
Florida (1861)
Georgia (404)
Hawaii (4)
Idaho (68)
Illinois (1046)
India (83)
Indiana (584)
Iowa (24)
Japan (482)
Kansas (136)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1553)
Massachusetts (9168)
Michigan (383)
Minnesota (706)
Mississippi (7)
Missouri (150)
Montana (37)
Nebraska (30)
Nevada (138)
New Hampshire (89)
New Jersey (3346)
New Mexico (33)
New York (3293)
North Carolina (1711)
North Dakota (10)
Northern California (6061)
Ohio (384)
Oklahoma (23)
Oregon (54)
Pennsylvania (2491)
Puerto Rico (26)
Rhode Island (53)
South America (1668)
South Carolina (74)
South Dakota (1)
Southern California (4856)
Tennessee (200)
Texas (1979)
United States (44935)
Utah (377)
Vermont (1)
Virginia (316)
Washington D.C. (88)
Washington State (1029)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
There are 874,797 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
TerraPower Commits $450M to Build Radioisotope Production Plant
Constructing the cGMP facility will increase availability of actinium-225, a nuclear material central to radiopharmaceutical programs at AstraZeneca, Bristol Myers Squibb, Eli Lilly and Novartis.
March 18, 2026
·
2 min read
·
Nick Paul Taylor
Approvals
Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights
Protagonist Therapeutics will now sit back and collect cash from the J&J partnership, including an immediate $50 million payment.
March 18, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Global Study From Feinstein Institutes to Unlock Secrets of Lupus Remission
March 18, 2026
·
5 min read
Press Releases
Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer
March 18, 2026
·
6 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 18, 2026
March 18, 2026
·
2 min read
Press Releases
Newron Announces Nominations to Its Board of Directors at Upcoming Annual General Meeting
March 18, 2026
·
7 min read
Press Releases
Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms
March 18, 2026
·
1 min read
Press Releases
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026
March 18, 2026
·
6 min read
Press Releases
ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests
March 18, 2026
·
6 min read
Press Releases
Circle Pharma to Present New Clinical and Preclinical Data at AACR 2026
March 18, 2026
·
3 min read
1 of 87,480
Next
